Celgene Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest Celgene careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: June 19, 2019, 8:12 am
Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: June 19, 2019, 8:12 am
Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: June 19, 2019, 8:12 am
Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: June 19, 2019, 8:12 am
Description Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of hum...
Posted: June 19, 2019, 8:12 am

Viewing page 1 of 70|Next Page

  Newsfeed | Subscribe  

Have you been paying attention to shares of Celgene (CELG)? Shares have been on the move with the stock up 2.6% over the past month. The stock hit a new 52-week high of $97.54 in the previous session. ...
Posted: June 19, 2019, 12:37 am
An immunotherapy drug for cancers that was in limbo following Bristol-Myers Squibb’s acquisition of Celgene earlier this year has been returned to its original developer. As part of the ...
Posted: June 18, 2019, 5:51 am
Chinese drugmaker BeiGene Ltd. will take back the global rights to its cancer drug tislelizumab from Celgene Corp., following the U.S. company’s blockbuster merger with Bristol-Myers Squibb Co. ...
Posted: June 17, 2019, 4:00 am
You've probably heard the expression, "It ain't over until the fat lady sings." For Celgene (NASDAQ: CELG), the fat lady is on stage ready to belt out her solo. Although there was some uncertainty ...
Posted: June 16, 2019, 6:19 am
Jun 15, 2019 (Euclid Infotech Ltd via COMTEX) -- Lyfebulb, a chronic disease-focused, patient-empowerment platform that connects patients with industry to support user-driven innovation, and Celgene ...
Posted: June 15, 2019, 1:06 pm

Viewing page 1 of 3|Next Page